The present invention relates to an isolated polypeptide comprising (a) the amino acid sequence set forth in SEQ ID NO: 1; or (b) an amino acid sequence that is at least 95% identical to SEQ ID NO: 1, nucleic acids, vectors and host cells encoding the same, as well as therapeutic treatments based thereon.